1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psychedelic Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Psilocybin
1.2.3 LSD
1.2.4 MDMA
1.2.5 DMT
1.2.6 Ketamine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Psychedelic Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Depressive Disorders
1.3.3 Post-Traumatic Stress Disorders
1.3.4 Substance Abuse Disorders
1.3.5 Obsessive Compulsive Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Psychedelic Medicine Market Perspective (2017-2028)
2.2 Psychedelic Medicine Growth Trends by Region
2.2.1 Psychedelic Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Psychedelic Medicine Historic Market Size by Region (2017-2022)
2.2.3 Psychedelic Medicine Forecasted Market Size by Region (2023-2028)
2.3 Psychedelic Medicine Market Dynamics
2.3.1 Psychedelic Medicine Industry Trends
2.3.2 Psychedelic Medicine Market Drivers
2.3.3 Psychedelic Medicine Market Challenges
2.3.4 Psychedelic Medicine Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Psychedelic Medicine Players by Revenue
3.1.1 Global Top Psychedelic Medicine Players by Revenue (2017-2022)
3.1.2 Global Psychedelic Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Psychedelic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psychedelic Medicine Revenue
3.4 Global Psychedelic Medicine Market Concentration Ratio
3.4.1 Global Psychedelic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psychedelic Medicine Revenue in 2021
3.5 Psychedelic Medicine Key Players Head office and Area Served
3.6 Key Players Psychedelic Medicine Product Solution and Service
3.7 Date of Enter into Psychedelic Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Psychedelic Medicine Breakdown Data by Type
4.1 Global Psychedelic Medicine Historic Market Size by Type (2017-2022)
4.2 Global Psychedelic Medicine Forecasted Market Size by Type (2023-2028) 5 Psychedelic Medicine Breakdown Data by Application
5.1 Global Psychedelic Medicine Historic Market Size by Application (2017-2022)
5.2 Global Psychedelic Medicine Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Psychedelic Medicine Market Size (2017-2028)
6.2 North America Psychedelic Medicine Market Size by Type
6.2.1 North America Psychedelic Medicine Market Size by Type (2017-2022)
6.2.2 North America Psychedelic Medicine Market Size by Type (2023-2028)
6.2.3 North America Psychedelic Medicine Market Share by Type (2017-2028)
6.3 North America Psychedelic Medicine Market Size by Application
6.3.1 North America Psychedelic Medicine Market Size by Application (2017-2022)
6.3.2 North America Psychedelic Medicine Market Size by Application (2023-2028)
6.3.3 North America Psychedelic Medicine Market Share by Application (2017-2028)
6.4 North America Psychedelic Medicine Market Size by Country
6.4.1 North America Psychedelic Medicine Market Size by Country (2017-2022)
6.4.2 North America Psychedelic Medicine Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada 7 Europe
7.1 Europe Psychedelic Medicine Market Size (2017-2028)
7.2 Europe Psychedelic Medicine Market Size by Type
7.2.1 Europe Psychedelic Medicine Market Size by Type (2017-2022)
7.2.2 Europe Psychedelic Medicine Market Size by Type (2023-2028)
7.2.3 Europe Psychedelic Medicine Market Share by Type (2017-2028)
7.3 Europe Psychedelic Medicine Market Size by Application
7.3.1 Europe Psychedelic Medicine Market Size by Application (2017-2022)
7.3.2 Europe Psychedelic Medicine Market Size by Application (2023-2028)
7.3.3 Europe Psychedelic Medicine Market Share by Application (2017-2028)
7.4 Europe Psychedelic Medicine Market Size by Country
7.4.1 Europe Psychedelic Medicine Market Size by Country (2017-2022)
7.4.2 Europe Psychedelic Medicine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Psychedelic Medicine Market Size (2017-2028)
8.2 Asia-Pacific Psychedelic Medicine Market Size by Type
8.2.1 Asia-Pacific Psychedelic Medicine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Psychedelic Medicine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Psychedelic Medicine Market Share by Type (2017-2028)
8.3 Asia-Pacific Psychedelic Medicine Market Size by Application
8.3.1 Asia-Pacific Psychedelic Medicine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Psychedelic Medicine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Psychedelic Medicine Market Share by Application (2017-2028)
8.4 Asia-Pacific Psychedelic Medicine Market Size by Region
8.4.1 Asia-Pacific Psychedelic Medicine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Psychedelic Medicine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Psychedelic Medicine Market Size (2017-2028)
9.2 Latin America Psychedelic Medicine Market Size by Type
9.2.1 Latin America Psychedelic Medicine Market Size by Type (2017-2022)
9.2.2 Latin America Psychedelic Medicine Market Size by Type (2023-2028)
9.2.3 Latin America Psychedelic Medicine Market Share by Type (2017-2028)
9.3 Latin America Psychedelic Medicine Market Size by Application
9.3.1 Latin America Psychedelic Medicine Market Size by Application (2017-2022)
9.3.2 Latin America Psychedelic Medicine Market Size by Application (2023-2028)
9.3.3 Latin America Psychedelic Medicine Market Share by Application (2017-2028)
9.4 Latin America Psychedelic Medicine Market Size by Country
9.4.1 Latin America Psychedelic Medicine Market Size by Country (2017-2022)
9.4.2 Latin America Psychedelic Medicine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Psychedelic Medicine Market Size (2017-2028)
10.2 Middle East & Africa Psychedelic Medicine Market Size by Type
10.2.1 Middle East & Africa Psychedelic Medicine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Psychedelic Medicine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Psychedelic Medicine Market Share by Type (2017-2028)
10.3 Middle East & Africa Psychedelic Medicine Market Size by Application
10.3.1 Middle East & Africa Psychedelic Medicine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Psychedelic Medicine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Psychedelic Medicine Market Share by Application (2017-2028)
10.4 Middle East & Africa Psychedelic Medicine Market Size by Country
10.4.1 Middle East & Africa Psychedelic Medicine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Psychedelic Medicine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 COMPASS Pathways PLC
11.1.1 COMPASS Pathways PLC Company Details
11.1.2 COMPASS Pathways PLC Business Overview
11.1.3 COMPASS Pathways PLC Psychedelic Medicine Introduction
11.1.4 COMPASS Pathways PLC Revenue in Psychedelic Medicine Business (2017-2022)
11.1.5 COMPASS Pathways PLC Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Psychedelic Medicine Introduction
11.2.4 Pfizer Revenue in Psychedelic Medicine Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Psychedelic Medicine Introduction
11.3.4 Eli Lilly Revenue in Psychedelic Medicine Business (2017-2022)
11.3.5 Eli Lilly Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Psychedelic Medicine Introduction
11.4.4 GlaxoSmithKline Revenue in Psychedelic Medicine Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Cybin Inc
11.5.1 Cybin Inc Company Details
11.5.2 Cybin Inc Business Overview
11.5.3 Cybin Inc Psychedelic Medicine Introduction
11.5.4 Cybin Inc Revenue in Psychedelic Medicine Business (2017-2022)
11.5.5 Cybin Inc Recent Developments
11.6 Field Trip Health
11.6.1 Field Trip Health Company Details
11.6.2 Field Trip Health Business Overview
11.6.3 Field Trip Health Psychedelic Medicine Introduction
11.6.4 Field Trip Health Revenue in Psychedelic Medicine Business (2017-2022)
11.6.5 Field Trip Health Recent Developments
11.7 ATAI Life Sciences
11.7.1 ATAI Life Sciences Company Details
11.7.2 ATAI Life Sciences Business Overview
11.7.3 ATAI Life Sciences Psychedelic Medicine Introduction
11.7.4 ATAI Life Sciences Revenue in Psychedelic Medicine Business (2017-2022)
11.7.5 ATAI Life Sciences Recent Developments
11.8 NUMINUS WELLNESS
11.8.1 NUMINUS WELLNESS Company Details
11.8.2 NUMINUS WELLNESS Business Overview
11.8.3 NUMINUS WELLNESS Psychedelic Medicine Introduction
11.8.4 NUMINUS WELLNESS Revenue in Psychedelic Medicine Business (2017-2022)
11.8.5 NUMINUS WELLNESS Recent Developments
11.9 MindMed
11.9.1 MindMed Company Details
11.9.2 MindMed Business Overview
11.9.3 MindMed Psychedelic Medicine Introduction
11.9.4 MindMed Revenue in Psychedelic Medicine Business (2017-2022)
11.9.5 MindMed Recent Developments
11.10 HAVN Life Sciences
11.10.1 HAVN Life Sciences Company Details
11.10.2 HAVN Life Sciences Business Overview
11.10.3 HAVN Life Sciences Psychedelic Medicine Introduction
11.10.4 HAVN Life Sciences Revenue in Psychedelic Medicine Business (2017-2022)
11.10.5 HAVN Life Sciences Recent Developments
11.11 Seelos Therapeutics
11.11.1 Seelos Therapeutics Company Details
11.11.2 Seelos Therapeutics Business Overview
11.11.3 Seelos Therapeutics Psychedelic Medicine Introduction
11.11.4 Seelos Therapeutics Revenue in Psychedelic Medicine Business (2017-2022)
11.11.5 Seelos Therapeutics Recent Developments
11.12 Jannsen
11.12.1 Jannsen Company Details
11.12.2 Jannsen Business Overview
11.12.3 Jannsen Psychedelic Medicine Introduction
11.12.4 Jannsen Revenue in Psychedelic Medicine Business (2017-2022)
11.12.5 Jannsen Recent Developments
11.13 Acadia Pharmaceuticals
11.13.1 Acadia Pharmaceuticals Company Details
11.13.2 Acadia Pharmaceuticals Business Overview
11.13.3 Acadia Pharmaceuticals Psychedelic Medicine Introduction
11.13.4 Acadia Pharmaceuticals Revenue in Psychedelic Medicine Business (2017-2022)
11.13.5 Acadia Pharmaceuticals Recent Developments
11.14 Intellipharmaceutics
11.14.1 Intellipharmaceutics Company Details
11.14.2 Intellipharmaceutics Business Overview
11.14.3 Intellipharmaceutics Psychedelic Medicine Introduction
11.14.4 Intellipharmaceutics Revenue in Psychedelic Medicine Business (2017-2022)
11.14.5 Intellipharmaceutics Recent Developments
11.15 Revive Therapeutics
11.15.1 Revive Therapeutics Company Details
11.15.2 Revive Therapeutics Business Overview
11.15.3 Revive Therapeutics Psychedelic Medicine Introduction
11.15.4 Revive Therapeutics Revenue in Psychedelic Medicine Business (2017-2022)
11.15.5 Revive Therapeutics Recent Developments
11.16 Mydecine Innovations Group
11.16.1 Mydecine Innovations Group Company Details
11.16.2 Mydecine Innovations Group Business Overview
11.16.3 Mydecine Innovations Group Psychedelic Medicine Introduction
11.16.4 Mydecine Innovations Group Revenue in Psychedelic Medicine Business (2017-2022)
11.16.5 Mydecine Innovations Group Recent Developments
11.17 Red Light Holland
11.17.1 Red Light Holland Company Details
11.17.2 Red Light Holland Business Overview
11.17.3 Red Light Holland Psychedelic Medicine Introduction
11.17.4 Red Light Holland Revenue in Psychedelic Medicine Business (2017-2022)
11.17.5 Red Light Holland Recent Developments
11.18 Braxia Scientific
11.18.1 Braxia Scientific Company Details
11.18.2 Braxia Scientific Business Overview
11.18.3 Braxia Scientific Psychedelic Medicine Introduction
11.18.4 Braxia Scientific Revenue in Psychedelic Medicine Business (2017-2022)
11.18.5 Braxia Scientific Recent Developments
11.19 Mind Cure Health
11.19.1 Mind Cure Health Company Details
11.19.2 Mind Cure Health Business Overview
11.19.3 Mind Cure Health Psychedelic Medicine Introduction
11.19.4 Mind Cure Health Revenue in Psychedelic Medicine Business (2017-2022)
11.19.5 Mind Cure Health Recent Developments
11.20 Entheon Biomedical
11.20.1 Entheon Biomedical Company Details
11.20.2 Entheon Biomedical Business Overview
11.20.3 Entheon Biomedical Psychedelic Medicine Introduction
11.20.4 Entheon Biomedical Revenue in Psychedelic Medicine Business (2017-2022)
11.20.5 Entheon Biomedical Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
